{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"61.8","upperLimit":"82.7","value":"73.9"},{"groupId":"OG001","lowerLimit":"28.2","upperLimit":"87.8","value":"66.7"},{"groupId":"OG002","lowerLimit":"25.3","upperLimit":"82.7","value":"60.0"},{"groupId":"OG003","lowerLimit":"32.9","upperLimit":"89.2","value":"70.0"},{"groupId":"OG004","lowerLimit":"64.0","upperLimit":"89.5","value":"80.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"40"}],"units":"Participants"}],"description":"Kaplan-Meier estimate of the percentage of being alive and relapse free one year after the date of transplant. (Events=relapse, death)","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients who met eligibility criteria and received transplant.","id":"OG000","title":"All Transplant Participants"},{"description":"Patients who met eligibility criteria, received transplant, and received 1x10\\^5 cells/kg","id":"OG001","title":"Dose 1"},{"description":"Patients who met eligibility criteria, received transplant, and received 1x10\\^6 cells/kg","id":"OG002","title":"Dose 2"},{"description":"Patients who met eligibility criteria, received transplant, and received 1x10\\^7 cells/kg","id":"OG003","title":"Dose 3"},{"description":"Patients who met eligibility criteria, received transplant, and were assigned the MED dose of 1x10\\^7 cells/kg","id":"OG004","title":"Phase 2"}],"paramType":"NUMBER","populationDescription":"Patients who met eligibility criteria and received transplant.","reportingStatus":"POSTED","timeFrame":"One year after receiving transplant","title":"One-year Event Free Survival (EFS) After Completion of the Protocol","type":"PRIMARY","unitOfMeasure":"percentage of participants"}